HBW Advisory Services’s State Street SPDR S&P Biotech ETF XBI Stock Holding History
Bought
Maintained
Sold
Other funds holding XBI
JFG
HBW Advisory Services's XBI Position: Q2 2026 in Review
HBW Advisory Services reduced its State Street SPDR S&P Biotech ETF (XBI) stake by 0.36% in Q2 2026, selling an estimated $1.22K and leaving 2,507 shares worth $397K. The position accounts for 0.04% of the portfolio, ranked #337.
HBW Advisory Services first reported a position in XBI in Q4 2019 and has held it in 4 quarters since. The position peaked at $519K in Q4 2019. 933 funds tracked by Wall St. Rank hold XBI as of Q2 2026.
- HBW Advisory Services held 2,507 shares of State Street SPDR S&P Biotech ETF worth $397K as of Q2 2026.
- HBW Advisory Services sold 9 State Street SPDR S&P Biotech ETF shares in Q2 2026, an estimated $1.22K.
- State Street SPDR S&P Biotech ETF made up 0.04% of HBW Advisory Services's portfolio in Q2 2026, its #337 holding.
- HBW Advisory Services first reported a position in State Street SPDR S&P Biotech ETF in Q4 2019 and has held it in 4 quarters since.
- HBW Advisory Services's State Street SPDR S&P Biotech ETF position peaked at $519K in Q4 2019.
- 933 funds tracked by Wall St. Rank held State Street SPDR S&P Biotech ETF as of Q2 2026.
Based on HBW Advisory Services's 13F filing for Q2 2026, filed 16 Jul 2026.